tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Financial Statements

Compare
0 Followers

Basilea Pharmaceutica Financial Overview

Basilea Pharmaceutica's market cap is currently CHF552.36M. The company's EPS TTM is CHF6.403; its P/E ratio is 7.17; Basilea Pharmaceutica is scheduled to report earnings on ―, and the estimated EPS forecast is CHF1.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueCHF 157.63MCHF 147.76MCHF 148.12MCHF 127.63MCHF 134.38M
Gross ProfitCHF 130.84MCHF 120.96MCHF 124.05MCHF 103.58MCHF 115.51M
Operating IncomeCHF 19.20MCHF 16.34MCHF 1.17MCHF -23.26MCHF -17.20M
EBITDACHF 23.18MCHF 26.21MCHF 6.72MCHF -2.24MCHF -14.13M
Net IncomeCHF 10.45MCHF 12.15MCHF -6.83MCHF -14.72MCHF -22.42M
Balance Sheet
Cash & Short-Term InvestmentsCHF 59.90MCHF 86.57MCHF 149.95MCHF 167.28MCHF 131.04M
Total AssetsCHF 173.29MCHF 220.85MCHF 247.27MCHF 229.79MCHF 221.47M
Total DebtCHF 128.61MCHF 187.14MCHF 218.96MCHF 242.32MCHF 197.74M
Net DebtCHF 68.71MCHF 150.57MCHF 164.00MCHF 186.71MCHF 143.22M
Total LiabilitiesCHF 183.29MCHF 241.56MCHF 305.87MCHF 331.84MCHF 314.43M
Stockholders' EquityCHF -10.00MCHF -20.71MCHF -58.61MCHF -102.05MCHF -92.96M
Cash Flow
Free Cash FlowCHF 13.21MCHF 3.75MCHF -32.88MCHF -56.40MCHF -64.24M
Operating Cash FlowCHF 14.24MCHF 7.06MCHF -32.02MCHF -54.13MCHF -63.84M
Investing Cash FlowCHF -1.03MCHF 91.65MCHF 3.58MCHF -34.96MCHF -404.00K
Financing Cash FlowCHF -57.30MCHF -45.25MCHF 16.64MCHF 45.07MCHF 1.31M
Currency in CHF

Basilea Pharmaceutica Earnings and Revenue History

Basilea Pharmaceutica Debt to Assets

Basilea Pharmaceutica Cash Flow

Basilea Pharmaceutica Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis